MARKET

VKTXW

VIKING THERAPEUT
VKTXW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-8.4559
-
1.378
-
Viking Therapeutics Q4 net loss widens, hurt by higher R&D expenses
Reuters · 19m ago
BUZZ-Novo Nordisk, obesity firms drop on report of Hims Wegovy pill copy launch
Reuters · 6d ago
Viking Therapeutics Inc. published an update to their financial calendar
Reuters · 02/04 21:08
Viking Therapeutics Inc. kündigt Veröffentlichung neuer Finanzergebnisse an
Reuters · 02/04 21:08
BUZZ-US-listed Novo shares slip after company flags sharp 2026 sales drop
Reuters · 02/03 17:48
STRUCTURE THERAPEUTICS DOWN 5.3%, VIKING THERAPEUTICS DOWN 3.3%, AMGEN DOWN 1.4%
Reuters · 02/03 17:33
OBESITY DRUGMAKERS AND DEVELOPERS FALL AFTER RIVAL NOVO NORDISK WARNS OF STEEP 2026 SALES DECLINE
Reuters · 02/03 17:33
Viking Therapeutics stellt neue klinische Fortschritte bei Medikamenten gegen Adipositas und Stoffwechselkrankheiten vor
Reuters · 02/02 21:37
More

Webull offers VIKING THERAPEUT stock information, including NASDAQ: VKTXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VKTXW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VKTXW stock methods without spending real money on the virtual paper trading platform.